Does PEMBROLIZUMAB Cause Pulmonary fibrosis? 134 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 134 reports of Pulmonary fibrosis have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.2% of all adverse event reports for PEMBROLIZUMAB.
134
Reports of Pulmonary fibrosis with PEMBROLIZUMAB
0.2%
of all PEMBROLIZUMAB reports
22
Deaths
56
Hospitalizations
How Dangerous Is Pulmonary fibrosis From PEMBROLIZUMAB?
Of the 134 reports, 22 (16.4%) resulted in death, 56 (41.8%) required hospitalization, and 16 (11.9%) were considered life-threatening.
Is Pulmonary fibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 134 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Pulmonary fibrosis?
METHOTREXATE (2,912)
ADALIMUMAB (2,277)
RITUXIMAB (2,192)
ETANERCEPT (1,926)
TOCILIZUMAB (1,886)
ABATACEPT (1,828)
HYDROXYCHLOROQUINE (1,740)
LEFLUNOMIDE (1,731)
PREDNISONE (1,692)
INFLIXIMAB (1,595)
Which PEMBROLIZUMAB Alternatives Have Lower Pulmonary fibrosis Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G